Natera

Tumor DNA sequencing and liquid biopsy that identify targetable variants and biomarkers to guide treatment.

Vetted listingTakes insuranceFinancial aid availableFeatured

Testing2 offerings

Consented intake · your records travel with you · nothing moves without your sign-off

Why Natera exists

Natera offers DNA sequencing that maps tumor tissue for variants, including whole exome data useful when a personalized vaccine is being considered, along with liquid biopsy analysis of blood. It is for patients who want to uncover the genetic changes driving their cancer and gather biomarkers that can guide treatment and monitor disease progression, giving doctors more specific options to discuss.

First Signatera result in about 3 to 4 weeks; follow-up tests usually take 7 to 10 daysCAP · Accredited laboratoryCLIA · Certified laboratoryISO 13485 · Certified

1
Tumor profiling
The patient's tumor and blood are used to find the unique changes, or mutations, in their cancer.
2
A personalized test is built
That information is used to create a custom Signatera MRD test, personalized from the patient's own tumor tissue.
3
Ongoing blood tests
Each time it is ordered as part of routine follow-up blood tests, Signatera looks for small pieces of circulating tumor DNA to signal relapse earlier.

Prefer the source? Natera's own site has more.

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

What they offer

Testing· 2

Gather distinctive biomarkers that can guide treatment and monitor disease progression
Uncover what genetic coding is driving my cancer, especially those variants of interest that can be targeted for treatment

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Natera handles billing.

Insurance

Accepted

Financial aid

Available

Prior auth

Required

In-network carriers

MedicareBlue Cross Blue ShieldUnitedHealthcareAetnaCignaHumana

Build a personalized cost estimate Natera billing & patient resources

Common questions about Natera

How much does Natera cost?

$0-$100 with insurance. Confirm current pricing directly when you connect.

Does Natera take insurance?

Natera accepts insurance; In-network carriers include Medicare, Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna; financial assistance is available. Add your plan on OpenCancer to check coverage before you commit.

How does Natera work?

1. Tumor profiling — The patient's tumor and blood are used to find the unique changes, or mutations, in their cancer. 2. A personalized test is built — That information is used to create a custom Signatera MRD test, personalized from the patient's own tumor tissue. 3. Ongoing blood tests — Each time it is ordered as part of routine follow-up blood tests, Signatera looks for small pieces of circulating tumor DNA to signal relapse earlier.

How long does Natera take?

First Signatera result in about 3 to 4 weeks; follow-up tests usually take 7 to 10 days

How do I connect with Natera?

Through OpenCancer's consented intake: enter your details once, choose exactly which records travel with the request, and sign a consent that covers this connection only. Nothing is shared without your sign-off.

Understand this before you decide

Signatera for patients

Guide from Natera

Signatera FAQ

Guide from Natera

Oncology billing

Guide from Natera

Ask about this service

Answers grounded in Natera's details here. Educational only; your oncologist directs treatment.

Ask OpenCancer · answers grounded in this storefront

Who this is for

Cancer types served

bladderbreastcolorectalesophagealgastriclungmelanomaovarianpancreatic

Generally requires prior treatment history — eligibility confirmed during intake.

Also consider

Other providers in similar categories.

BostonGene

6 offerings

Gather distinctive biomarkers that can guide treatment and monitor disease progression

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.